ALNY · Company research
Alnylam Pharmaceuticals, Inc. (ALNY): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 223.94 | $35,394,404,760 | 33686086760.00 | 49.383668704616056 | — | — | 27.4173744875858671 | 26.1383459639411041 | 121.1954526030324198 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.